Introduction and hypothesis Opioid use, addiction, and overdose are a growing epidemic in the USA. Our objective was to determine whether the amount of opioid medication prescribed following gynecologic and pelvic reconstructive surgery is insufficient, adequate, or in excess. We hypothesized that we were overprescribing postoperative opioids. Methods Participants who were at least 18 years old and underwent gynecologic and/or pelvic reconstructive surgery from April through August 2016 were eligible to participate. Routine practice for pain management is to prescribe 30 tablets of opioids for major procedures and ten to 15 tablets for minor procedures. At the 2-week postoperative visit, participants completed a questionnaire regarding the number of tablets prescribed and used, postoperative pain control, and relevant medical history. Fisher's exact test was used to compare data. Results Sixty-five participants completed questionnaires. Half (49.1%) reported being prescribed more opioids than needed, while two (3.5%) felt the amount was less than needed.
Introduction
Prescription opioid addiction and overdose is a growing problem in the USA. Deaths from drug overdoses involving opioids have increased from approximately 4000 in 1999 to 14,800 in 2008. Many of these deaths are attributed to prescription opioids, such as morphine, hydrocodone, and oxycodone [1] . In 2013, the US Department of Health and Human Services deemed deaths from prescription opioid overdose an epidemic [2] , which is partly related to high opioid prescribing practices among healthcare providers and subsequent dependency or abuse of these analgesics by patients [3] . Previous research has shown that many patients keep their leftover opioids for future use [4, 5] . The 2013 National Survey on Drug Use and Health reported that most adults who obtain opioids for nonmedical use acquire them from family or friends who were prescribed opioids [6] . These findings suggest that changing prescribing practices and reducing the quantity of opioids prescribed may decrease the potential for nonmedical use of these medications.
While the US National Institutes for Health Centers for Disease Control and Prevention (CDC) has published guidelines to improve opioid prescription practices for chronic pain [7] , there is limited data about the need or use of opioid analgesia following surgical procedures, including gynecologic and pelvic floor reconstructive surgery. Given the lack of guidelines for prescription practices for acute pain, clinicians often use best judgment and experience to determine the amount of postoperative analgesia to prescribe for each patient. The objective of this quality improvement project was to determine whether the amount of prescription opioids used after gynecologic and pelvic floor reconstructive surgical procedures in our practice was insufficient, adequate, or in excess of patients' needs. We hypothesized that we were likely overprescribing and sought to determine whether health conditions, such as anxiety or depression, were associated with higher use of opioids and what patients did with their leftover analgesia.
Materials and methods
This was a quality improvement project, and the institutional review board at Mount Auburn Hospital determined that it did not meet criteria for research on human subjects prior to the start of the project. All patients who were at least 18 years old and underwent gynecologic and pelvic floor reconstructive procedures in our practice from April through August 2016 were eligible to participate. Patients were not eligible if they could not read or write English or if they could not complete the questionnaire for any other reason, such as having dementia.
In our practice, we routinely prescribe 30 opioid tablets for major and 10 to 15 for minor procedures for postoperative pain management, unless the patient has a contraindication such as an allergic reaction or intolerance to opioids. All patients are also offered a prescription for ibuprofen. Patients undergoing major procedures are scheduled for a preoperative visit, at which time they are given an opioid prescription and are counseled to bring leftover tablets to their 2-week postoperative visit for counting and safe disposal. As patients undergoing minor procedures do not routinely have a preoperative visit, they are counseled and given their prescriptions on the day of surgery.
At the 2-week postoperative visit, all participants completed a questionnaire to evaluate their postoperative opioid usage, the amount of opioids prescribed, postoperative pain control experience, relevant medical history such as anxiety, depression, chronic pain, or substance abuse, and what they did with any leftover opioids. All information was self-reported and did not include information about long-term or current opioid use. If a participant did not bring the leftover tablets, then she estimated the number of tablets used in the first 2 weeks after surgery.
Given the number of different gynecologic and pelvic floor reconstructive procedures and the various combinations of procedures performed on each patient, we categorized participants into mutually exclusive groups based on their primary procedure. If a participant underwent more than one procedure, she was placed in the group deemed the most invasive, with abdominal laparotomy being the most invasive, followed by laparoscopic/robotic surgery, vaginal surgery, midurethral sling, sacral neuromodulation, and other minor procedures. We also dichotomized participants by whether they underwent a major or minor procedure. Major operative procedures included laparotomy, laparoscopic/robotic, or vaginal surgeries that involved pelvic reconstructive surgery and/or concurrent hysterectomy. Minor operative procedures included midurethral slings, sacral neuromodulation, vaginal mesh, vaginal cyst or diverticulum excision, and hysteroscopy. To assess how chronic conditions may have influenced participants' opinions about how many tablets they were given, we compared those who felt they were given more tablets than needed to those who felt they were given adequate or too few tablets. Data are presented as number (%) or median [interquartile range (IQR)]. Categorical data were compared using the chi-square test. Data were stored using Research Electronic Data Capture (REDCap) and analyzed using SAS 9.4 (SAS institute, Cary, NC, USA).
Results
Sixty-five patients participated in this quality-improvement project. Eight participants did not receive a prescription for opioids and were excluded from analysis: four were prescribed ibuprofen only, and four were not prescribed any pain medication. Three (30.8%) of these eight underwent laparoscopic/robotic surgery, two (25.0%) vaginal surgery, and three (30.8%) minor procedures. Among the 57 participants included in the analysis, the median age was 53.0 (46.0-63.0) years: 75.4% had a major procedure, 24.6% underwent a minor procedure, and 57.9% underwent either a laparoscopic or robotic surgery. Of the other surgical procedures, three (5.3%) underwent a laparotomy, seven (12.3%) vaginal surgery, 11 (19.3%) midurethral sling, and three (5.3%) sacral neuromodulation (Table 1) . One third (33.3%) of participants reported a history of anxiety, 30.4% a history of depression, and 21.4% a history of chronic pain (Table 1) . Fifty-one (89.5%) participants reported they were prescribed oxycodone/acetaminophen, four (7.0%) hydromorphone, two (3.5%) acetaminophen/codeine, and one (1.8%) hydrocodone/acetaminophen and morphine. Forty-nine (86.0%) participants reported being prescribed ibuprofen in addition to opioids.
Among participants who underwent major procedures, those who underwent a laparotomy reported using the highest median number of opioid tablets (Table 2) .
When asked their opinion on the number of opioid tablets prescribed, most participants who underwent laparoscopic/ robotic surgeries or sacral neuromodulation procedures felt they were given more than they needed (57.6% and 66.7%, respectively). Most participants who underwent laparotomy or midurethral sling procedures felt they were given an adequate number (66.7% and 63.6%, respectively; Table 3 ). Only two (3.5%) participants felt the amount prescribed was less than appropriate; one had a midurethral sling and one a vaginal procedure. Though not significant, participants who underwent major surgery were more likely to report they felt they were prescribed more opioid tablets than needed (53.5%) compared with those who underwent a minor surgery (35.7%; p = 0.47).
At the 2-week postoperative visit, participants were asked how many opioid tablets they had remaining: 38 (66.7%) said they had excess tablets. Among the 29 who underwent major procedures, the median number of tablets remaining was 15.0 (6.0-28.0); among the nine who underwent minor procedures, the amount was 9.0 (6.0-15.0). Of the 38 participants with leftover tablets, 16 (42.1%) reported they planned to keep their excess for future use, six (15.8%) reported discarding them prior to their 2-week postoperative visit, four (10.5%) brought their excess to their visit, eight (21.1%) planned to discard them, one (2.6%) did not know what to do with them, and three (7.9%) did not answer the question. Participants' opinions about the number of tablets prescribed based on their history of chronic conditions are presented in Table 4 . Although not statistically significant, participants with anxiety were less likely to report being given more tablets than needed compared with participants without anxiety (44.4% vs 57.1%; p = 0.38). This also was true of participants with and without depression (37.5% vs. 58.3%; p = 0.17) and those with and without chronic pain (33.3% vs. 60.0%; p = 0.10). The participant who reported current use of recreational drugs felt she was given more opioid tablets than needed.
Discussion
More than half of the participants reported being prescribed more opioids than needed, and the median number of opioid tablets used by the 2-week postoperative visit was < 10 tablets for all types of surgeries except laparotomy. This indicates overprescribing of opioids for many procedures. Among patients reporting having leftover tablets, more than half kept them at home to either discard or use later. Though not statistically significant, participants with a history of anxiety, depression, and/or chronic pain were less likely to think they were prescribed more tablets than needed.
Overprescribing of opioids is a major contributor to abuse of these medications. Swenson et al., showed that after minimally invasive urogynecologic surgery, the median number of opioid tablets used was 13, and participants only used one third of the amount prescribed [8] . Bates et al. surveyed adult patients who underwent surgery in a urology practice and showed that only 58.0% of the prescribed pain medication was used and 67.0% of participants had excess medication [5] . In a cohort study by Bartels and colleagues, 53.0% of participants reported taking fewer than five opioid tablets following a cesarean delivery and 45.0% reported the same following thoracic surgery [9] . Based on these studies and our own findings, surgeons in a variety of specialties appear to be overprescribing opioid analgesia, leading to an excess of medication at home. In addition to overprescribing, at-home storage is another potential contributor to the opioid abuse epidemic. Despite preoperative counseling and instructions to bring excess opioids to their postoperative visit, only 10.5% of participants in our quality improvement project did so. Bates et al., found this in their study as well, reporting that 90.8% of patients who had excess postoperative opioids kept them at home, while < 1.0% of patients returned the excess opioids to a pharmacy [8] . In a study by Kennedy-Hendricks and colleagues, more than half (57.2%) of their participants had leftover opioids, and 48.8% planned to use them in the future [4] . Approximately 20% of these participants also reported sharing their leftover opioids with another person, with the main motivations being to help the other person manage pain or help with expenses [4] . Better education about the risks of opioid sharing and safe pill disposal may decrease the availability of excess opioids in the community. Opioids are commonly used to manage both acute postoperative and chronic nonmalignancy pain. Prior studies have shown that chronic pain is an independent risk factor for increased postoperative opioid use [7, 10, 11] , while other studies have shown that anxiety is also linked to an increase in opioid use [12, 13] . Although our results did not show a statistically significant difference between patients with and without anxiety, depression, or chronic pain, participants with these health conditions seemed to be less likely to think they were overprescribed opioids. Further investigation incorporating validated questionnaires for assessment of anxiety and depression, however, is needed to assess this more adequately. Additionally, assessing opioid needs preoperatively in patients with chronic pain would be beneficial, as consultation with a chronic pain specialist or psychopharmacologist may be required, depending on the severity of the patient's symptoms and baseline use of opioids.
Limitations of this project include the small sample size from a single female pelvic medicine and reconstructive surgery practice and that we did not assess whether chronic pain patients on long-term opioid medications altered their normal intake postoperatively to manage pain. Furthermore, we did not use a validated questionnaire to collect data; we are not aware of such a questionnaire being available and therefore developed our own. Lastly, we were unable to confirm the exact number of tablets leftover for most participants, as most did not bring them to their postoperative appointment, and we thus relied on patient recall. Strengths of this project included timing of the questionnaire at 2 weeks after surgery, which maximized the accuracy of recall. Additionally, inclusion of a wide variety of gynecologic surgeries without restriction to pelvic reconstructive surgeries only provides greater generalizability of the results.
Our study evaluated three important aspects regarding current opioid prescription practices: amount of opioid analgesia used, how patients handle excess tablets, and patient perceptions about the amount of postoperative analgesia needed. All three are fundamental to better understanding the opioid prescription abuse epidemic in the USA. Our results will improve Data presented as n (%) our current prescribing practices and decrease the number of opioid tablets prescribed, as it appears that the current prescribing practice exceeds the actual requirement for postoperative pain management. Additional research with larger samples and more diverse populations is necessary to better assess postoperative analgesia requirements and study the impact for specific, high-risk patient populations, such as those with chronic pain.
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